The Pediatric Brain Tumor Consortium (PBTC) was formed by the National Cancer Institute (NCI) in 1999 to improve the treatment of primary brain tumors in children. The PBTC is dedicated to the study of correlative tumor biology and new therapies for primary CNS tumors of childhood. The 9 hospitals in the consortium conduct clinical trials for anti-cancer drugs.